NCT02140983View on ClinicalTrials.gov

Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Insulin ResistanceDementia
Interventions
DRUG

Liraglutide

90 days of liraglutide up to 1.8mg/day.

DRUG

Placebo

Placebo medication

Trial Locations (1)

94305

Stanford Department of Psychiatry, Stanford

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

Stanford University

OTHER

NCT02140983 - Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes | Biotech Hunter | Biotech Hunter